Literature DB >> 14762701

Lincomycin, clindamycin and their applications.

J Spízek1, T Rezanka.   

Abstract

Lincomycin and clindamycin are lincosamide antibiotics used in clinical practice. Both antibiotics are bacteriostatic and inhibit protein synthesis in sensitive bacteria. They may even be bactericidal at the higher concentrations that can be reached in vivo. Clindamycin is usually more active than lincomycin in the treatment of bacterial infections, in particular those caused by anaerobic species; and it can also be used for the treatment of important protozoal diseases, e.g. malaria, most effectively in combination with primaquine. Resistance to lincomycin and clindamycin may be caused by methylation of 23S ribosomal RNA, modification of the antibiotics by specific enzymes or active efflux from the periplasmic space. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14762701     DOI: 10.1007/s00253-003-1545-7

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  27 in total

1.  A heme peroxidase with a functional role as an L-tyrosine hydroxylase in the biosynthesis of anthramycin.

Authors:  Katherine L Connor; Keri L Colabroy; Barbara Gerratana
Journal:  Biochemistry       Date:  2011-09-23       Impact factor: 3.162

2.  Absolute bioavailability of cis-mirincamycin and trans-mirincamycin in healthy rhesus monkeys and ex vivo antimalarial activity against Plasmodium falciparum.

Authors:  Phisit Khemawoot; David Saunders; Maneerat Rasameesoraj; Victor Melendez; Rawiwan Imerbsin; Colin Ohrt; Susan Fracisco; Paktiya Teja-Isavadharm
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

3.  Enhanced lincomycin production by co-overexpression of metK1 and metK2 in Streptomyces lincolnensis.

Authors:  Yurong Xu; Guoqing Tan; Meilan Ke; Jie Li; Yaqian Tang; Sitong Meng; Jingjing Niu; Yansheng Wang; Ruihua Liu; Hang Wu; Linquan Bai; Lixin Zhang; Buchang Zhang
Journal:  J Ind Microbiol Biotechnol       Date:  2018-03-24       Impact factor: 3.346

4.  Quantum mechanical studies of lincosamides.

Authors:  Katarzyna Kulczycka-Mierzejewska; Joanna Trylska; Joanna Sadlej
Journal:  J Mol Model       Date:  2011-11-25       Impact factor: 1.810

5.  Antimalarial Natural Products.

Authors:  David G I Kingston; Maria Belen Cassera
Journal:  Prog Chem Org Nat Prod       Date:  2022

6.  HLA-B*51:01 is strongly associated with clindamycin-related cutaneous adverse drug reactions.

Authors:  Y Yang; S Chen; F Yang; L Zhang; G Alterovitz; H Zhu; J Xuan; X Yang; H Luo; J Mu; L He; X Luo; Q Xing
Journal:  Pharmacogenomics J       Date:  2016-08-16       Impact factor: 3.550

7.  TetR-Type Regulator SLCG_2919 Is a Negative Regulator of Lincomycin Biosynthesis in Streptomyces lincolnensis.

Authors:  Yurong Xu; Meilan Ke; Jie Li; Yaqian Tang; Nian Wang; Guoqing Tan; Yansheng Wang; Ruihua Liu; Linquan Bai; Lixin Zhang; Hang Wu; Buchang Zhang
Journal:  Appl Environ Microbiol       Date:  2018-12-13       Impact factor: 4.792

8.  Mutasynthesis of lincomycin derivatives with activity against drug-resistant staphylococci.

Authors:  Dana Ulanova; Jitka Novotná; Yvona Smutná; Zdenek Kameník; Radek Gazák; Miroslav Sulc; Petr Sedmera; Stanislav Kadlcík; Kamila Plhácková; Jirí Janata
Journal:  Antimicrob Agents Chemother       Date:  2009-11-16       Impact factor: 5.191

Review 9.  Actinomycetes: A Never-Ending Source of Bioactive Compounds-An Overview on Antibiotics Production.

Authors:  Davide De Simeis; Stefano Serra
Journal:  Antibiotics (Basel)       Date:  2021-04-22

10.  Clonal spread of antimicrobial-resistant Escherichia coli isolates among pups in two kennels.

Authors:  Kazuki Harada; Erika Morimoto; Yasushi Kataoka; Toshio Takahashi
Journal:  Acta Vet Scand       Date:  2011-02-17       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.